Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Astrazeneca Says Etcamah Approved In US For HR+ Breast Cancer

    Picture of AstraZeneca logoAstraZeneca
    07/09/2026 08:01
    BRIEF-Astrazeneca Says Etcamah Approved In US For HR+ Breast Cancer
    Sept 7 (Reuters) - AstraZeneca PLC AZN.L:
    • ASTRAZENECA PLC  - ETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER
    • ASTRAZENECA PLC  - ETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER
    • ASTRAZENECA - FDA APPROVES ETCAMAH WITH CDK4/6 INHIBITOR FOR ESR1 MUTATION IN HR-POSITIVE, HER2-NEGATIVE BREAST CANCER
    • ASTRAZENECA - ACCELERATED APPROVAL BASED ON SERENA-6 PHASE III TRIAL PRESENTED AT 2025 ASCO
    • ASTRAZENECA - ETCAMAH COMBINATION SAFETY PROFILE CONSISTENT WITH KNOWN PROFILES, NO NEW SAFETY CONCERNS
    Source text: ID:nRSG5602Ta
    Further company coverage: AZN.L

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on AstraZeneca

    See all news